Efficacy and Safety of Remimazolam Compared to Midazolam for Sedation During Endoscopic Ultrasonography: A Single‐Center Retrospective Cohort Study
Open Access
Abstract
Objectives: Remimazolam is a novel ultra–short‐acting benzodiazepine that may offer advantages over conventional sedatives in endoscopic procedures. Evidence for its use in pancreatobiliary endoscopic ultrasonography (EUS) is limited. We compared the efficacy and safety of remimazolam and midazolam in outpatient pancreatobiliary EUS. Methods: This retrospective study included outpatients undergoing diagnostic pancreatobiliary EUS between July 2024 and July 2025. Patients received either remimazolam (initial 0.2 mg/kg, top‐up 0.1 mg/kg [high‐risk patients: 0.16 mg/kg, 0.08 mg/kg]) or midazolam. The target sedation depth was Modified Observer's Assessment of Alertness/Sedation ≤3, procedures were performed without supplemental oxygen, and pentazocine was co‐administered. The primary outcome was rapid recovery (meeting all criteria: modified Aldrete score ≥6 at 5 min, ≥9 at 30 min, ambulation ≥3 m at 30 min). Secondary outcomes included sedation success (all: EUS completion, without >2 top‐ups within 10 min, without rescue sedation, without agitation requiring interruption), recovery time, flumazenil use, and adverse events. Results: We analyzed 139 patients (remimazolam, n = 75; midazolam, n = 64). Rapid recovery was more frequent with remimazolam (70.7% vs. 25.0%, p < 0.001). Sedation success was higher (92.0% vs. 73.4%, p = 0.005), recovery was shorter (median 34 vs. 55 min, p < 0.001), and flumazenil use was lower (4.0% vs. 45.3%, p < 0.001). Hypoxemia (SpO 2 p = 0.707), but all episodes were mild and reversible with airway support/oxygen. Hypotension was rare and comparable. Conclusions: Remimazolam provided faster recovery and higher sedation success than midazolam in outpatient pancreatobiliary EUS. Supplemental oxygen before sedation is a reasonable option to enhance safety.Keywords
This publication has 33 references indexed in Scilit:
- Adverse Events Associated with Flumazenil Treatment for the Management of Suspected Benzodiazepine Intoxication – A Systematic Review with Meta‐Analyses of Randomised TrialsBasic & Clinical Pharmacology & Toxicology, 2015
- Endoscopic ultrasonography using new functions for pancreatobiliary diseases: Current status and future perspectivesDigestive Endoscopy, 2015
- A Phase IIa, Randomized, Double-Blind Study of Remimazolam (CNS 7056) Versus Midazolam for Sedation in Upper Gastrointestinal EndoscopyAnesthesia & Analgesia, 2015
- The role of capnography during upper endoscopy in morbidly obese patients: a prospective studySurgery for Obesity and Related Diseases, 2015
- The effects of different loading doses of dexmedetomidine on sedationKorean Journal of Anesthesiology, 2014
- Propofol Sedation for ERCP Procedures: A Dilemna? Observations from an Anesthesia PerspectiveDiagnostic and Therapeutic Endoscopy, 2012
- Target-controlled propofol infusion during monitored anesthesia in patients undergoing ERCPGastrointestinal Endoscopy, 2004
- Pain on injection of propofolAnaesthesia, 1998
- The post-anesthesia recovery score revisitedJournal of Clinical Anesthesia, 1995
- VALIDITY AND RELIABILITY OF THE OBSERVERS ASSESSMENT OF ALERTNESS SEDATION SCALE - STUDY WITH INTRAVENOUS MIDAZOLAM1990